Since the coronavirus pandemic shut down the world, scientists have clamored to develop vaccines to prevent the spread and medicines that will cure the sick. But a virus’ main goal is to replicate and infect, so the virus can mutate to survive and continue on its journey. Looking at the coronavirus, you’ll see it has several mutations, including the most recently talked about delta variant sweeping over India and invading the rest of the globe.
This delta variant is about 4 times more transmissible and also more severe than the original Wuhan strain or the A-lineage. And Pfizer (NYSE: PFE), Moderna (NASDAQ: MRNA) and Johnson & Johnson (NYSE: JNJ) have come out to proclaim their respective vaccines’ effectiveness against this and other variants that cause COVID-19. In fact, real world scenarios in India show the effectiveness of the vaccines around 65% effective as opposed to the presumed 95%. That’s a significant decrease. But no matter the percentage rate effectiveness of the vaccines, the only way to win the battles to come is to develop effective therapeutics to complement the them.
Variants Now and to Come
The first strain of the coronavirus coming out of Wuhan is known as the A-lineage. Since the beginning, this highly variable RNA virus mutated to enhance its effectiveness at infecting the population, thereby creating the B-lineage, which includes everything from D614G to the current delta version.
Now, in Peru, medical professionals identified the start of a new lineage — C. That lineage includes the Lambda variant, which could be more deadly than the previous variants of SARS-CoV-2, although the evidence to support that is insufficient at this time. That said, there is no way to stop the virus from mutating again and again into more deadly strains.
So, NanoViricides (NYSE: NNVC), a global leader in nanomedicine, decided to work on medicines to treat and heal the disease — no matter the mutation. And the drug already showed its oral effectiveness in animal models. It is moving as fast as possible to keep up with the prolific virus to get society to a point where it can live with something that looks like it’s here to stay. In addition to NanoViricides, other drugs are in the works to continue the fight against the coronavirus and its variants. These include Merck’s molnupiravir, which received several billion dollars in government funding and failed Phase 2 of clinical studies, and Pfizer’s oral antiviral protease inhibitor PF-07321332/ritonavir combination soon expected to enter Phase 2 clinical trials.
After the Pandemic’s end
The truth is, people are waiting for the pandemic to end, but SARS-CoV-2 and its variants will more than likely become endemic as it keeps coming back in more mutated versions for the foreseeable future. As UK Prime Minister Boris Johnson points out, the population will have to “learn to live with” it.
Because of the social and economic impact the virus has had, it’s unreasonable to think the entire world will continue to shut down indefinitely. As a global society, that’s not a sustainable existence. The better idea is to use vaccinations to limit the spread while developing therapeutics to treat the COVID-19 disease caused by the virus. That way, people can coexist with the coronavirus and get back to the kind of life society so desperately craves.

News
The Role of Nanotechnology in Space Exploration
Nanotechnology, which involves working with materials at the atomic or molecular level, is becoming increasingly important in space exploration. By improving strength, thermal stability, electrical conductivity, and radiation resistance, nanotechnology is helping create lighter, more [...]
New Study Challenges Beliefs About CBD in Pregnancy, Reveals Unexpected Risks
CBD is gaining popularity as a remedy for pregnancy symptoms like nausea and anxiety, but new research suggests it may not be as safe as many believe. A study from McMaster University found that [...]
Does COVID increase the risk of Alzheimer’s disease?
Scientists discover that even mild COVID-19 can alter brain proteins linked to Alzheimer’s disease, potentially increasing dementia risk—raising urgent public health concerns. A recent study published in the journal Nature Medicine investigated whether both mild and [...]
New MRI Study Reveals How Cannabis Alters Brain Activity and Weakens Memory
A massive new study sheds light on how cannabis affects the brain, particularly during cognitive tasks. Researchers analyzed over 1,000 young adults and found that both heavy lifetime use and recent cannabis consumption significantly reduced brain [...]
How to Assess Nanotoxicity: Key Methods and Protocols
With their high surface area and enhanced physicochemical properties, nanomaterials play a critical role in drug delivery, consumer products, and environmental technologies. However, their nanoscale dimensions enable interactions with cellular components in complex and [...]
Nanotech drug delivery shows lasting benefits, reducing need for repeat surgeries
A nanotechnology-based drug delivery system developed at UVA Health to save patients from repeated surgeries has proved to have unexpectedly long-lasting benefits in lab tests – a promising sign for its potential to help human patients. [...]
Scientists Just Found DNA’s Building Blocks in Asteroid Bennu – Could This Explain Life’s Origins?
Japanese scientists detected all five nucleobases — building blocks of DNA and RNA — in samples returned from asteroid Bennu by NASA’s OSIRIS-REx mission. NASA’s OSIRIS-REx mission brought back 121.6 grams of asteroid Bennu, unveiling nitrogen-rich organic matter, including DNA’s essential [...]
AI-Designed Proteins – Unlike Any Found in Nature – Revolutionize Snakebite Treatment
Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more effective, accessible, and affordable antivenom solutions. By utilizing advanced computational techniques and deep learning, this innovative [...]
New nanosystem offers hope for improved diagnosis and treatment of tongue cancer
A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and treatment of tongue squamous cell carcinoma (TSCC). By harnessing gold nanoparticles coupled with the HN-1 peptide, [...]
Global Trust in Science Is Stronger Than Expected – What’s Next?
A landmark global survey conducted across 68 countries has found that public trust in scientists remains robust, with significant support for their active involvement in societal and political matters. The study highlights the public’s [...]
Microplastics in the bloodstream may pose hidden risks to brain health
In a recent study published in the journal Science Advances, researchers investigated the impact of microplastics on blood flow and neurobehavioral functions in mice. Using advanced imaging techniques, they observed that microplastics obstruct cerebral blood [...]
AI Surveillance: New Study Exposes Hidden Risks to Your Privacy
A new mathematical model enhances the evaluation of AI identification risks, offering a scalable solution to balance technological benefits with privacy protection. AI tools are increasingly used to track and monitor people both online [...]
Permafrost Thaw: Unleashing Ancient Pathogens and Greenhouse Gases
Permafrost is a fascinating yet alarming natural phenomenon. It refers to ground that remains frozen for at least two consecutive years. Mostly found in polar regions like Siberia, Alaska, and Canada, permafrost plays a [...]
Frequent social media use tied to higher levels of irritability
A survey led by researchers from the Center for Quantitative Health at Massachusetts General Hospital and Harvard Medical School has analyzed the association between self-reported social media use and irritability among US adults. Frequent [...]
Australian oysters’ blood could hold key to fighting drug-resistant superbugs
Protein found in Sydney rock oysters’ haemolymph can kill bacteria and boost some antibiotics’ effectiveness, scientists discover An antimicrobial protein found in the blood of an Australian oyster could help in the fight against [...]
First U.S. H5N1 Death Sparks Urgency: Scientists Warn Bird Flu Is Mutating Faster Than Expected
A human strain of H5N1 bird flu isolated in Texas shows mutations enabling better replication in human cells and causing more severe disease in mice compared to a bovine strain. While the virus isn’t [...]